Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females

NCT05461573 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1542

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception
Change in Bone Mineral Density

Interventions

DRUG: Drospirenone

Sponsor

Insud Pharma

Collaborators

[object Object]